Table 2.
First clinical performances and diagnostic methods of the three patient populations: DCIS, DCIS-Mi, and IDC
| Parameter | DCIS | DCIS-Mi | IDC | P value |
|---|---|---|---|---|
| Total number |
73 |
72 |
721 |
|
|
First clinical performance |
|
|
|
|
| Nipple discharge |
9 (12.3) |
8 (11.1) |
63 (8.7) |
0.51 |
| Bloody |
4 (5.5) |
3 (4.2) |
44 (6.1) |
0.776 |
| Yellow |
5 (6.8) |
5 (6.9) |
19 (3.3) |
0.062 |
| Palpable tumor |
48 (65.8) |
50 (69.4) |
518 (71.8) |
0.52 |
| Pain |
3 (4.1) |
5 (5.9) |
37 (5.1) |
0.731 |
| Eczema |
1 (1.4) |
1 (1.4) |
29 (4.0) |
0.22 |
| Asymptomatic |
12 (16.4) |
8 (11.1) |
74 (10.3) |
0.27 |
|
Diagnostic methods |
|
|
|
|
| Ultrasound |
|
|
|
|
| Catheter widened |
65 (89) |
56 (77.8) |
450 (62.4) |
0.000 |
| Solid and cystic |
3 (4.1) |
1 (1.4) |
21 (2.9) |
0.589 |
| Nodular mass |
56 (76.7) |
53 (73.6) |
648 (89.9) |
0.003 |
| Structural disorder |
56 (76.7) |
44 (61.6) |
486 (67.4) |
0.125 |
| Calcifications |
37 (50.7) |
34 (47.2) |
342 (47.7) |
0.866 |
| Mammography |
|
|
|
|
| Calcifications |
60 (82.2) |
63 (87.5) |
631 (87.5) |
0.431 |
| Nodular mass | 30 (41.1) | 25 (34.7) | 532 (73.8) | 0.000 |
DCIS Ductal carcinoma in situ; IDC Infiltrating ductal carcinoma; Mi Microinvasion.